Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients

Clinical trial NCT01407601 · COMPLETED

Trial details

NCT number: NCT01407601
Sponsor: RWTH Aachen University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

CKD 5D, Hemodialysis

Start date: 2008-01-01
Primary completion: 2008-05-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.